Home/Filings/4/0000880431-08-000004
4//SEC Filing

GENAERA CORP 4

Accession 0000880431-08-000004

CIK 0000880431operating

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:02 PM ET

Size

12.9 KB

Accession

0000880431-08-000004

Insider Transaction Report

Form 4
Period: 2007-12-20
Kaye Mitchell D
Director10% Owner
Transactions
  • Purchase

    Common Stock, Par Value $0.002

    2007-12-21$2.42/sh+12,000$29,0423,817,474 total(indirect: See Footnotes)
  • Purchase

    Common Stock, Par Value $0.002

    2007-12-20$1.81/sh+90,200$163,5063,777,342 total(indirect: See Footnotes)
  • Purchase

    Common Stock, Par Value $0.002

    2007-12-20$1.74/sh+28,132$48,8853,805,474 total(indirect: See Footnotes)
  • Purchase

    Common Stock, Par Value $0.002

    2007-12-21$2.23/sh+117,659$262,3093,935,133 total(indirect: See Footnotes)
Footnotes (3)
  • [F1]As of December 21, 2007, Xmark Opportunity Fund, L.P., a Delaware limited partnership ("Opportunity LP"), held 634,058 common shares, $0.002 par value per share (the "Common Shares"), of Genaera Corporation, a Delaware corporation (the "Company"), and warrants to purchase up to 210,375 Common Shares of the Company at an exercise price of $3.6606 per share and up to 12,500 Common Shares of the Company at an exercise price of $18.90 per share. All of the warrants provide that the holder does not have the right to exercise any portion of the warrant, to the extent that after giving effect to such exercise, such holder would beneficially own in excess of 4.99% of the number of Common Shares of the Company outstanding immediately after giving effect to such exercise.
  • [F2]As of December 21, 2007, Xmark Opportunity Fund, Ltd., a Cayman Islands exempted company ("Opportunity Ltd"), held 1,562,128 Common Shares of the Company and warrants to purchase up to 411,205 Common Shares of the Company at an exercise price of $3.6606 per share and up to 12,500 Common Shares of the Company at an exercise price of $18.90 per share. As of December 21, 2007, Xmark JV Investment Partners, LLC, a Delaware limited liability company ("JV Partners"), held 1,738,947 Common Shares of the Company and warrants to purchase up to 27,500 Common Shares of the Company at an exercise price of $18.90 per share. All of the warrants provide that the holder does not have the right to exercise any portion of the warrant, to the extent that after giving effect to such exercise, such holder would beneficially own in excess of 4.99% of the number of Common Shares of the Company outstanding immediately after giving effect to such exercise.
  • [F3]Xmark Opportunity Partners, LLC, a Delaware limited liability company ("Opportunity Partners"), is the sole member of the investment manager of Opportunity LP and Opportunity Ltd, and the investment manager of JV Partners, and, as such, possesses sole power to vote and direct the disposition of all securities of the Company held by Opportunity LP, Opportunity Ltd and JV Partners. The reporting person's interest in the securities reported herein is limited to the extent of his pecuniary interest in Opportunity LP, Opportunity Ltd and JV Partners, if any. Mitchell D. Kaye and David C. Cavalier, the Chief Executive Officer and Chief Operating Officer, respectively, of Xmark Capital Partners, LLC, the Managing Member of Opportunity Partners, share voting and investment power with respect to all securities beneficially owned by Opportunity Partners.

Issuer

GENAERA CORP

CIK 0000880431

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000880431

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:02 PM ET
Size
12.9 KB